Brief: Diasorin Q1 Adj. EBITDA EUR 313 Mln
06/05/2025 16:44
May 6 (Reuters) - DiaSorin SpA DIAS.MI: Q1 REVENUE EUR 313 MILLION Q1 NET PROFIT EUR 52 MILLION Q1 ADJUSTED EBITDA EUR 107 MILLION CONFIRMS 2025 GUIDANCE Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21